TECH stock forecast
Our latest prediction for Bio-Techne Corp.'s stock price was made on the Sept. 9, 2019 when the stock price was at 183.56$.
In the short term (2weeks), TECH's stock price should outperform the market by 1.90%. During that period the price should oscillate between -3.15% and +4.53%.
In the medium term (3months), TECH's stock price should outperform the market by 1.93%. During that period the price should oscillate between -7.12% and +11.76%.Get email alerts
Create a solid portfolio with TECH
About Bio-Techne Corp.
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Protein Sciences and Diagnostics &Genomics. The Protein Sciences segment develops and manufactures purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. This segment also includes protein analysis solutions that offer researchers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics &Genomics segment develops and manufactures diagnostic products, including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays, including the ExoDx Prostate(IntelliScore) test (EPI) for prostate cancer diagnosis. This segment also manufactures and sells advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use. The company was founded on 1976 and is headquartered in Minneapolis, MN.
At the moment the company generates 714M USD in revenues.
On its last earning announcement, the company reported a profit of 2.47$ per share.
The book value per share is 28.58$
Three months stock forecastSept. 9, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|